4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Savara Inc. (SVRA) operates in the Biotechnology industry and is headquartered in Yardley, United States with about 70 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, SVRA reported $0M in revenue and ($119M) in net income.
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($123M) | ($102M) | ($59M) | ($38M) | — |
| Net Income | ($119M) | ($96M) | ($55M) | ($38M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($38M) | ($33M) | ($30M) | ($31M) | ($28M) |
| Net Income | ($37M) | ($32M) | ($30M) | ($30M) | ($27M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $253M | $213M | $178M | $140M | — |
| Total Liabilities | $50M | $41M | $37M | $32M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SVRA viewer.
About TickerBase · Data methodology & sources